The objectives and outcomes of this grant opportunity align with the Roadmap and Implementation Plan for the Dementia, Ageing and Aged Care Mission.
The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that:
Stream 1 (Priority area 2.3; Targeted Call for Research) conduct implementation research focused on addressing inequalities in uptake of prevention activities for:
Stream 2 (Priority area 3.1; Targeted Call for Research): conduct implementation research to understand the barriers and enablers to, and impact of, the adoption of the key components of high-quality care for older Australians across:
The intended outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by:
Stream 1 (Priority area 2.3; Targeted Call for Research): implementing interventions that extend healthy, active years of life amongst vulnerable populations.
Stream 2 (Priority area 3.1; Targeted Call for Research): improving implementation of best practice care for older Australians.
This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health and Aged Care.
Further information on the Medical Research Future Fund is available from the Department of Health and Aged Care’s website.
A list of Eligible Organisations can be found on the NHMRC List of MRFF Eligible Organisations webpage.
Grant Activity Timeframe:
Within 5 years of the execution of the grant schedule.
Total Amount Available (AUD):
$24,300,000.00
Estimated Grant Value (AUD):
From $0.00 to $5,000,000.00
Instructions for Application Submission:
Applicants are advised to read the Grant Guidelines thoroughly and liaise with the MRFF Eligible Organisation that will submit the application to identify any specific requirements that the Organisation might have.
Applications must be submitted electronically using NHMRC’s online granting system (Sapphire).
Other Instructions:
Minimum Data closes at 5:00pm (ACT Local Time) on 23 July 2025.
Questions should be submitted no later than 1:00pm (ACT Local Time) on 13 August 2025.
Investigator Grants are highly competitive (≈13% success), especially for early-to-mid career researchers (EMCRs ≈10%), while senior fellows fare slightly better.
Larger grants correlate with higher publication output and citation indices; senior investigators holding larger awards produce more papers and have higher h‑indexes .
Applications are evaluated on research quality, innovation, significance to practice/policy, feasibility, risk management, and translation into impact .
Projects should propose substantial advances or paradigm shifts, not incremental improvements .
Demonstrating consumer/community engagement, workforce development capabilities, and collaborative partnerships is a key selection criterion .
In health research, applying Indigenous excellence criteria can strengthen applications for work involving Aboriginal and Torres Strait Islander communities .
Institutions like the Kirby Institute see above-average success (~37%) by leveraging strong research environments and leadership.
Centre-level and multi-disciplinary teams, as seen in program and centre grants, tend to be more successful .
EMCRs face stricter competition, and success rates for women are lower in senior career stages (~18% women vs 20% men overall; EMCR fellowships ~10% for women vs ~18% for men) .
NHMRC accounts for career disruptions but adjustments are limited (adds ~1 year to publications) .
Serving on peer-review panels is modestly associated with higher funding success .
However, submitting resubmitted applications without major improvements correlates with lower success in subsequent rounds .
Time devoted to proposal writing does not significantly increase funding chances beyond a certain point—quality over quantity matters .
✅ Key Takeaways
Success Factor | What to Demonstrate |
---|---|
Strong publication record | High-impact papers, strong h-index |
Career standing | Senior/fellowship status boosts chances |
Research quality & innovation | Paradigm-shifting, methodologically robust |
Consumer & end-user engagement | CO-design, community input, workforce development |
Collaborative and institutional environment | Multi-disciplinary, well-supported teams |
Address gender/career gaps | Clearly note and adjust for disruptions |
Peer-review insight | Participation enhances proposal quality |
Strategic proposal writing | Prioritize clarity, impact, feasibility—not time spent |
Choose the right scheme: EMCR applicants may consider the specific EMCR stream to match career stage.
Show proven impact: Emphasize citation metrics, translational outcomes, and institutional support.
Build partnerships: Include collaborators, end-users, and Indigenous stakeholders when relevant.
Highlight innovation and feasibility: Articulate risks and pathway to translation, with clear aims.
Prepare for peer review: Gain insights by serving on committees or discussing with funded investigators.
Use gender equity provisions wisely: Document disruptions and use NHMRC tools to contextualize CVs.
Revise smartly on resubmission: Learn from feedback—don’t simply resubmit unchanged applications.
Focus on message, not hours: Aim for clarity, not volume; reviewers are judging content, not effort.
Applications will only be accepted from approved MRFF Eligible Organisations. A list of approved MRFF Eligible Organisations is available on the NHMRC website.
Applications must satisfy all the requirements set out in the MRFF – Dementia, Ageing and Aged Care Mission – 2025 Dementia, Ageing and Aged Care Grant Opportunity Guidelines.
Eligible Countries:
Sponsor Institute/Organizations: National Health and Medical Research Council
Sponsor Type: Government/Federal
Address: Level 1, 16 Marcus Clarke Street, Canberra, ACT 2601
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Aug 20, 2025
Aug 20, 2025
$3,236,250
AUD 5000000
Affiliation: National Health and Medical Research Council
Address: Level 1, 16 Marcus Clarke Street, Canberra, ACT 2601
Website URL: https://www.grants.gov.au/Go/Show?GoUuid=af182dac-31e2-4e63-a45d-01bfac9379b2
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.